News

Filter

Lexicon Pharma updates on clinical pipeline

21-02-2013

US drug developer Lexicon Pharmaceutical (Nasdaq: LXRX) yesterday updated its drug development pipeline,…

BiotechnologyDiabetesGastro-intestinalsLexicon PharmaceuticalsLX1032LX1033LX4211OncologyResearchtelotristat etiprate

COMPANY SPOTLIGHT

Menarini

Back to top